Omega Therapeutics(OMGA) - 2024 Q1 - Quarterly Results

Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress CAMBRIDGE, Mass., May 6, 2024 (GLOBE NEWSWIRE) – Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced financial results for the first quarter ended March 31, 2024, and highlighted recent Company progress. "Our consistent focus on execution in the past quarter led to mean ...